Summary
A pooled analysis of MR CLEAN and IMS III trial data from the patient subgroup with National Institutes of Health Stroke Scale score ≥ 20 demonstrated the benefit of endovascular therapy in addition to intravenous tissue plasminogen activator treatment in patients presenting with severe stroke.
- endovascular
- IMS III
- MR CLEAN
- pooled analysis
- stroke
- tissue plasminogen activator
- © 2015 SAGE Publications
Tools
Endovascular Intervention Beneficial in Pooled Analysis of MR CLEAN and IMS III
Permalink:
Table of contents
Cited By...
- No citing articles found.